Multiple Myeloma Stage II
1 clinical trials · Condition
◉ Watch Multiple Myeloma Stage II
| Record | Firm | Date |
|---|---|---|
| Rivaroxaban or Aspirin As Thromboprophylaxis in Multiple Myeloma (NCT03428373) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2019-01-17 |
Track Multiple Myeloma Stage II automatically
Every clearance here is in the API, with alerts when new ones post.